Search clinical trials for: norelgestromin ethinyl estradiol; triphasil.

Total 501 results

AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

HIV-1 Infection

United States, Peru, Puerto Rico, Brazil, Botswana, Kenya, South Africa, Thailand
Organon and Co

Completed

An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)

Infertility
Sun Yat-sen University

Completed

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Advanced Breast Cancer | Antibiotic | Stable Disease With a Trend of Progression

China
William Beaumont Hospitals

Terminated

Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives

Contraception

United States
Hoffmann-La Roche

Completed

A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers

Healthy Volunteer

United States, France
Bayer

Completed

Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive

Switzerland, Portugal, Chile, Italy, Korea, Republic of, Venezuela, Philippines, Colombia, Thailand, Argentina, Germany, Russian Federation, United Kingdom, Czech Republic
Peking University Third Hospital

Unknown

Moxifloxacin_QT Study in Chinese Healthy Volunteer

QT Interval Prolongation

China
Bayer

Completed

Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

Contraception

Germany
Boehringer Ingelheim

Active, not recruiting

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

Healthy

Germany
AstraZeneca

Terminated

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Non-alcoholic Steatohepatitis

Germany
BioMarin Pharmaceutical

Completed

A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects

Phenylketonuria

United States
University of Campinas, Brazil

Terminated

Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

Endophthalmitis

Brazil
Virginia Commonwealth University

Completed

Oral Contraceptives in the Metabolic Syndrome

Cardiovascular Diseases | Obesity | Insulin Resistance | Metabolic Syndrome X

United States
Bayer

Completed

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

Anti-Infective Agents

Japan
GlaxoSmithKline

Completed

VEG111485: A QTc Study of Pazopanib

Carcinoma, Renal Cell

United States
Hoffmann-La Roche

Completed

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Healthy Volunteer

United States
Bristol-Myers Squibb

Completed

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Chronic Hepatitis C

United States, Canada
Bayer

Completed

Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults

Healthy

Germany
Bayer

Completed

Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

Lung Diseases | Bronchitis, Chronic

Italy, Spain, United States, Greece, Chile, Germany, France, Mexico, Argentina, Israel, South Africa, Ireland, Brazil, United Kingdom, Andorra
Bayer

Completed

SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB) (SYMPROVE III)

Chronic Bronchitis

Germany
Bayer

Completed

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Abscess, Intra-Abdominal | Secondary Peritonitis

China
Bayer

Completed

Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

Electrocardiography | QTc Evaluation

Singapore, Australia, Germany, United Kingdom
Bayer

Completed

Treatment of Patients With Acute Sinusitis

Acute Bacterial Sinusitis

China, France, Germany, Indonesia, Malaysia, Saudi Arabia, Singapore, Philippines, Austria, Jordan, Lebanon, Romania, Bahrain, Egypt, United Arab Emirates, Kuwait, Netherlands, Pakistan, Yemen
Iuliu Hatieganu University of Medicine and Pharmacy

Unknown

Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome | Endothelial Dysfunction

Romania
Takeda

Recruiting

A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

Healthy Volunteers

United States
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants

Pain

United States
Manuel Luque Ramírez
Instituto de Salud Carlos III

Completed

Phlebotomy and Polycystic Ovary Syndrome

Hyperandrogenism | Metabolic Cardiovascular Syndrome

Spain
Universitaire Ziekenhuizen KU Leuven

Unknown

Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients

Infertility | Endometriosis

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

Acute Coronary Syndrome

United States
Bayer

Completed

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

Pneumonia

Croatia, France, Hungary, Jordan, Kazakhstan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Russian Federation, Ukraine
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
Bayer

Completed

VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis (VICTOR)

Chronic Bronchitis | Disease Exacerbation

China
Bayer

Completed

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Bronchitis, Chronic

Slovakia, Kazakhstan, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Russian Federation, Ukraine, Bosnia and Herzegovina, Albania
Daiichi Sankyo

Recruiting

A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

COPD Exacerbation Acute

China
Amgen

Completed

A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

Electrocardiography

United States
Vertex Pharmaceuticals Incorporated

Completed

An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

Cystic Fibrosis

United States
Illinois Retina Associates
Alcon Research

Completed

Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

Intravitreal Injection Patients

United States
Peking Union Medical College Hospital

Unknown

Reason Evaluation of Initial Treatment Failure in Patients With CAP (RECAP)

Community-acquired Pneumonia

China
Eli Lilly and Company

Completed

A Study of LY2216684 in Healthy Females

Depressive Disorder, Major

United States
GlaxoSmithKline

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
Institute of Tropical Medicine, Belgium
University of Liverpool; Rinda Ubuzima

Completed

Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy (Ring-Plus)

Contraception

Rwanda
Bayer

Completed

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox (SPEED)

Maxillary Sinusitis

United States, Argentina
Bayer

Completed

BAY12-8039: 5 Days for Sinusitis vs Placebo

Sinusitis

United States
Bayer

Completed

Greatest International Antiinfective Trial With Avelox (GIANT)

Bronchial Diseases | Bronchitis, Chronic

Switzerland, Poland, China, Croatia, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Philippines, Taiwan, Austria, Colombia, Hong Kong, Mexico, Slovenia, Turkey, Egypt, Morocco, Netherlands, Pakistan, Brazil, El...
University Ghent

Completed

Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass (DRUG10_MOXI)

Body Weight | Gastric Bypass

Belgium
AstraZeneca

Completed

Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval

Healthy

United Kingdom
Novartis Pharmaceuticals

Completed

Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

Post Operative Endophthalmitis

India
Alexion Pharmaceuticals
Celerion

Completed

A Study of the Cardiac Effects of ALXN2050 in Healthy Adults

Healthy

United States
University of Chicago
Organon

Completed

Acceptability of the NuvaRing Among Students (ACCEPT)

Birth Control Compliance

United States
Bayer

Completed

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs (MERAK)

Infectious Diseases

Italy

Search clinical trials for: norelgestromin ethinyl estradiol; triphasil.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations